Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commencement of Commercial Activities with TTNET

9 Jul 2012 07:00

RNS Number : 1706H
Phorm Inc
09 July 2012
 



 9July 2012

Phorm, Inc. ('Phorm' or 'the Company')

 

Commencement of Commercial Activities in Turkey with TTNET

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, announces that it has today commenced commercial activities in Turkey.

 

Following our announcement in October 2011 that we had signed an agreement with an ISP in an important Southern European market, we have now installed our system within the network of leading Turkish ISP TTNET, which has around 6m Turkish broadband lines.

 

We are in the process of sending 'opt-in' invitations to TTNET's subscribers and, as with Phorm's operations in both Brazil and Romania, we have been delighted with the results which are in excess of our expectations.

 

We are also very pleased to announce that we have begun commercial activities and are now serving advertisements using our system.

 

Kent Ertugrul, CEO of Phorm, commented:

 

"We are very excited by the start of commercial activities in Turkey. TTNET is the fourth ISP with whom we have deployed and this reflects a growing realization by ISPs around the world that Phorm's solution provides significant benefits for consumers, ISPs, advertisers and publishers alike.

 

The scale of our operations in Turkey represents a significant revenue opportunity for Phorm and the initial advertiser and publisher reaction to our proposition has been very encouraging.

 

We are also very pleased with the reaction of consumers. Our opt-in rates reflect both the value of our consumer proposition and the importance of our market-leading approach to privacy protection.

 

Momentum is clearly now building and the launch in Turkey will assist in accelerating our ongoing discussions with a considerable pipeline of ISPs globally.

 

We look forward to updating the market on further commercial progress in Turkey and elsewhere in due course."

 

-Ends-

 

Enquiries:

 

Phorm, Inc.

Mark Williams: +44 (0)20 7297 2326 (analysts and investors)

Alex Laity +44 (0)20 7297 2710 (media)

 

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

 

Hudson Sandler +44 20 7796 4133

Charlie Jack

Charlie Barker

 

 

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers. A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors. For more information, please visit: www.phorm.com

 

 

About TTNET

Founded in 2006, TTNET is a leading company in both the Turkish communications and entertainment industries. TTNET offers voice, Internet, and TV services to its customers. TTNET also partners with Avea to offer customers an entire range of mobile communication services including GSM and 3G under TTNET Mobil brand.

 

TTNET's value added services extend beyond Internet access services to include television entertainment through Tivibu Web which makes cinema and TV available on the web, Tivibu Ev which provides IPTV services on TVs at home, TTNET Muzik, a popular service that provides free access to millions of music tracks, and Playstore, a digital gaming platform. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGGNLRKGZZM
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.